Dr. Dino PratoEnvita Medical Centers · Founder and CEO at Envita Medical Centers

Is Anktiva the cure for cancer? #shorts

17 Feb 2026 · 0 min

Watch on YouTube

0:29

In this YouTube short, the speaker addresses the misconception that Anktiva (Atezolizumab) is a universal cure for cancer. He clarifies that the FDA has only approved Anktiva for treating invasive bladder cancer, though it is an immunotherapy that can kill tumors rather than merely manage them. The speaker notes that immunotherapies often have broader applications and can be used off‑label in precision oncology when a patient’s tumor microenvironment is suitable, but such use is not the same as a blanket cure.

Many believe that this antiva is the cure to cancer, but it's only been approved for invasive bladder cancer by the fda. But it's an immunotherapy, and immunotherapies usually have a pretty widespread usage beyond one cancer. And the key here is that it helps to shut down cancers by killing them, not just managing them, which we see with a lot of smart drugs. But this immunotherapy, like many others we have used in decades, can be used off label in a precision mechanism when the environment fits.